BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23176887)

  • 1. Salbutamol tolerance to bronchoprotection: course of onset.
    Stewart SL; Martin AL; Davis BE; Cockcroft DW
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
    Bhagat R; Kalra S; Swystun VA; Cockcroft DW
    Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
    Raissy HH; Harkins M; Esparham A; Kelly HW
    Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment.
    Drotar DE; Davis EE; Cockcroft DW
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid onset of tolerance to beta-agonist bronchodilation.
    Haney S; Hancox RJ
    Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma.
    O'Byrne PM; van der Linde J; Cockcroft DW; Gauvreau GM; Brannan JD; Fitzgerald M; Watson RM; Milot J; Davis B; O'Connor M; Hart L; Korducki L; Hamilton AL; Boulet LP
    J Allergy Clin Immunol; 2009 Dec; 124(6):1217-21. PubMed ID: 20004781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
    Lee DK; Jackson CM; Bates CE; Lipworth BJ
    Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
    Jonkers RE; Bantje TA; Aalbers R
    Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
    Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
    Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
    Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
    Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
    Bhagat R; Swystun VA; Cockcroft DW
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):47-52. PubMed ID: 8568137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
    Jokic R; Swystun VA; Davis BE; Cockcroft DW
    Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.